Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page adds new navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and standardizes the Intervention/Treatment heading. It also introduces metadata labels 'Last verified' and 'Last known status was:' plus a 'Revision: v3.6.0' indicator to reflect updated documentation structure.
    Difference
    2%
    Check dated 2026-06-14T05:05:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor behind-the-scenes update to the study record. This does not alter the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-06-07T01:42:04.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Virogen Biotechnology Inc. was added as sponsor and Angimmune LLC was removed as a collaborator. The study record revision was updated from v3.5.3 to v3.5.4.
    Difference
    0.3%
    Check dated 2026-05-16T10:27:01.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page’s site revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T22:40:01.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:14:59.000Z thumbnail image
  7. Check
    95 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 implemented. - Previous revision: v3.4.3 removed. - No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-03-20T00:22:17.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.